1. "Aun con dolor, hay que trabajar.". (January 2022) Authors: Astudillo, Olaya Journal: Lancet Issue: Volume 4:Number 1(2022) Page Start: e23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. "Even in pain, you have to work.". (January 2022) Authors: Astudillo, Olaya Journal: Lancet Issue: Volume 4:Number 1(2022) Page Start: e22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. "I still struggle to accept this condition". (January 2021) Authors: Morgan, Jules Journal: Lancet Issue: Volume 3:Number 1(2021) Page Start: e18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. "I want to be Wendy, not Wendy the ill person". (September 2019) Authors: Morgan, Jules Journal: Lancet Issue: Volume 1:Number 1(2019) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial. (April 2023) Authors: Bolhuis, Thomas E; Marsman, Diane E; den Broeder, Alfons A; den Broeder, Nathan; van der Maas, Aatke Journal: Lancet Issue: Volume 5:Number 4(2023) Page Start: e208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 2022: a banner year for systemic lupus erythematosus?. (July 2022) Authors: The Lancet Rheumatology, Journal: Lancet Issue: Volume 4:Number 7(2022) Page Start: e451 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 5-year efficacy and safety of secukinumab in patients with ankylosing spondylitis: end-of-study results from the phase 3 MEASURE 2 trial. (June 2020) Authors: Marzo-Ortega, Helena; Sieper, Joachim; Kivitz, Alan J; Blanco, Ricardo; Cohen, Martin; Pavelka, Karel; Delicha, Eumorphia M; Stefanska, Anna; Richards, Hanno B; Rohrer, Susanne Journal: Lancet Issue: Volume 2:Number 6(2020) Page Start: e339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study. (March 2021) Authors: Bergmann, Christina; Distler, Jörg H W; Treutlein, Christoph; Tascilar, Koray; Müller, Anna-Theresa; Atzinger, Armin; Matei, Alexandru-Emil; Knitza, Johannes; Györfi, Andrea-Hermina; Lück, Anja; Dees, Clara; Soare, Alina; Ramming, Andreas; Schönau, Verena; Distler, Oliver; Prante, Olaf; Ritt, Phi... Journal: Lancet Issue: Volume 3:Number 3(2021) Page Start: e185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A call for papers: EULAR 2021. (March 2021) Authors: Van Epps, Heather Journal: Lancet Issue: Volume 3:Number 3(2021) Page Start: e170 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A complex intervention to improve anxiety in people with systemic sclerosis during COVID-19. (June 2021) Authors: Newby, Jill M Journal: Lancet Issue: Volume 3:Number 6(2021) Page Start: e397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗